AAOpt 2024: Keeping contact lens wearers comfortable with Miebo

News
Video

David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.

David Geffen, OD, FAAO presented on his research using the eye drop perfluorohexyloctane, also known as Miebo, for contact lens wearers. His poster was titled, "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers."

Geffen explained that one of the main reasons for contact lens dropout is dry eye and discomfort. His study enrolled 46 contact lens wearers - 26 daily wearers and 20 monthly wearers - and had them use the Mibo drops 4 times per day for 30 days. The study looked at various metrics like meibomian scores, staining, visual acuity, osmolarity, and contact lens comfort. Surprisingly, the only statistically significant change was an increase in contact lens comfort. Geffen noted that most of the study participants continued using the drops with their contacts after the study concluded. Based on these findings, Geffen believes Mibo could be a valuable tool for improving contact lens retention and reducing dropouts due to discomfort. He stated that plans should be made to conduct further studies to see if the drops can be used directly on the contact lenses without any issues.

Currently, Geffen and many of his colleagues are already using Miebo off-label for contact lens patients, with good results. The main considerations are ensuring patients use the right drop size and frequency (2-3 times per day may be sufficient). Overall, there is an exciting potential new application for Mibo that could transform the contact lens experience for many patients. While more research is needed, the initial findings are very promising in terms of improving comfort and potentially reducing contact lens dropout rates long-term.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
© 2024 MJH Life Sciences

All rights reserved.